Back
Vanguard S&P 500 Growth Index Fund ETF Vs. Amphastar Pharmaceuticals, Inc. Industry Stock Comparison
Buy
64
VOOG
Vanguard S&P 500 Growth Index Fund ETF
Last Price:
$443.23
Seasonality Move:
2.37%
Sell
43
AMPH
Amphastar Pharmaceuticals, Inc.
Last Price:
$26.58
Seasonality Move:
-3.24%
Buy
64
Vanguard S&P 500 Growth Index Fund ETF (VOOG)
is a Buy
Is Vanguard S&P 500 Growth Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard S&P 500 Growth Index Fund ETF [VOOG] share price is $443.51. The Score for VOOG is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
VOOG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Amphastar Pharmaceuticals, Inc. (AMPH)
is a Sell
Is Amphastar Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Amphastar Pharmaceuticals, Inc. [AMPH] share price is $26.60. The Score for AMPH is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
AMPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VOOG Stock Price Chart
What is Vanguard S&P 500 Growth Index Fund ETF's stock price today?
-
The Vanguard S&P 500 Growth Index Fund ETF share price today is $443.51Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VOOG is experiencing buying pressure, which is a positive indicator for future bullish movement.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals, Inc.'s stock price today?
-
The Amphastar Pharmaceuticals, Inc. share price today is $26.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMPH is experiencing slight buying pressure.
VOOG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 82.52 | Buy |
| Relative Strength Index (14 RSI): | 52.08 | Buy |
| Chaikin Money Flow: | 150017 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (433.25 - 447.59) | Buy |
| Bollinger Bands (100): | (418.77 - 444.83) | Buy |
AMPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 53.22 | Buy |
| Chaikin Money Flow: | 120952 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.63 - 27.13) | Buy |
| Bollinger Bands (100): | (24.1 - 28.88) | Buy |
VOOG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 441.8 | Buy |
| 20-day SMA: | 442.81 | Buy |
| 50-day SMA: | 441 | Buy |
| 200-day SMA: | 397.68 | Buy |
| 8-day EMA: | 232.37 | Buy |
| 20-day EMA: | 113.68 | Buy |
| 50-day EMA: | 49.55 | Buy |
| 200-day EMA: | 12.94 | Buy |
AMPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26 | Buy |
| 20-day SMA: | 26.54 | Buy |
| 50-day SMA: | 25.53 | Buy |
| 200-day SMA: | 25.63 | Buy |
| 8-day EMA: | 26.22 | Buy |
| 20-day EMA: | 26.23 | Buy |
| 50-day EMA: | 26.1 | Buy |
| 200-day EMA: | 27.89 | Sell |
Vanguard S&P 500 Growth Index Fund ETF Earnings Growth & VOOG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Amphastar Pharmaceuticals, Inc. Earnings Growth & AMPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.20 per share.
Vanguard S&P 500 Growth Index Fund ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amphastar Pharmaceuticals, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||